Lucite deal toy commemorating the acquisition of Concurrent Real-Time, a provider of high-performance computational hardware and software solutions.
(21LJW165)Lucite deal toy commemorating the acquisition of Concurrent Real-Time, a provider of high-performance computational hardware and software solutions.
(21LJW165)Lucite tombstone, incorporating a shadow box, commemorating the close of High Street Real Estate Fund VI. The fund will target warehouse and distribution facilities in markets like Chicago, Northern New Jersey, Atlanta, Florida, and Texas.
(21ALJ304)Lucite deal toy marking the acquisition of California-based aerospace products and parts manufacturer Forrest Machining.
(21ALJ396)Crystal deal toy celebrating the sale of the Edgeworth Building in Richmond, Virginia. The former tobacco factory has been converted to office space.
(21AKL132)Crystal deal toy marking the acquisition by Realtor.com of Chicago-based Avail. The DIY property management platform provides online tools, educational content, and support for landlords and tenants.
(20ALJ489)Financial tombstone marking the successful placement by Siegfried Holding of a senior bond. The Swiss firm provides development and production services to the pharmaceutical and life sciences sectors.
(21LSS233)Custom crystal commemorative celebrating the launch of Wynzora Cream, a topical treatment for plaque psoriasis that received approval from the FDA (Food and Drug Administration) in 2020. The product launch resulted from a collaboration agreement between Denmark-based MC2 Therapeutics, and EPI Health, a specialty pharmaceutical firm headquartered in Charleston, South Carolina.
(21ADH022)Crystal deal toy celebrating a minority investment in Zevia, which specializes in zero sugar, zero calories beverages including sodas, energy drinks, organic teas, and sparkling water. The investment in the Los Angeles-based firm was made by Canadian fund manager CDPQ (Caisse dépôt et placement du Québec).
(21AJH002)Crystal deal toy commemorating a follow-on offering by electroCore, a bioelectronic medicine company.
(21AJH117)